A detailed history of Israel Englander (Millennium Management LLC) transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 22,188 shares of AURA stock, worth $244,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,188
Previous 70,717 68.62%
Holding current value
$244,068
Previous $555,000 69.91%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.81 - $7.89 $330,482 - $382,893
-48,529 Reduced 68.62%
22,188 $167,000
Q1 2024

May 15, 2024

BUY
$7.09 - $9.24 $501,383 - $653,425
70,717 New
70,717 $555,000
Q1 2023

May 15, 2023

BUY
$8.88 - $12.11 $277,775 - $378,812
31,281 New
31,281 $290,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $322M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.